Owners of cats with the commonly fatal disease feline infectious peritonitis (FIP) have long awaited a reliable source for the drug GS-441524 to treat FIP, and a recent announcement by Stokes Pharmacy is great news on this front. GS-441524, the active metabolite of the antiviral medication remdesivir, has been shown to be safe and effective in treating FIP in clinical trials, and it has been used in Australia and the UK for some time.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to CatWatch
Get the next year of CatWatch for just $20. And access all of our back issues and online content free of charge.
Subscribe today and save 50% off the regular rate!
